News
Then add the code below to the supportFile and setupNodeEvents function. // cypress/support/e2e.js import '@cypress/code-coverage/support' Please see the Test Apps section below. You can find a linked ...
After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...
LifeMD's growth accelerates with expanded insurance, new health products, and a 43% revenue boost. Click here to read our ...
Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...
The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden ...
The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...
The drugmaker accuses Premier Weight Loss of risking patients' health by selling altered, unsterile versions of its ...
The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...
The Centers for Medicare Medicaid Services (CMS) announced it will not proceed with a Biden administration proposal to expand ...
President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...
Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results